Schwiertz, Andreas

Microbiota and SCFA in lean and overweight healthy subjects

Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N. A., Donus, C., & Hardt, P. D. (2010) · Obesity

Gut microbiota and healthAdipokines, Inflammation, and Metabolic Diseases

Cited by 2,457

Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls

Unger, M. M., Spiegel, J., Dillmann, K.-U., Grundmann, D., Philippeit, H., Bürmann, J., Faßbender, K., Schwiertz, A., & Schäfer, K.-H. (2016) · Parkinsonism & Related Disorders

Gut microbiota and healthParkinson's Disease Mechanisms and Treatments

Cited by 1,159

A vegan or vegetarian diet substantially alters the human colonic faecal microbiota

Zimmer, J., Lange, B., Frick, J.-S., Sauer, H., Zimmermann, K., Schwiertz, A., Rusch, K., Klosterhalfen, S., & Enck, P. (2012) · European Journal of Clinical Nutrition

Gut microbiota and healthNutritional Studies and Diet

Cited by 465

Oligonucleotide Probes That Detect Quantitatively Significant Groups of Butyrate-Producing Bacteria in Human Feces

Hold, G. L., Schwiertz, A., Aminov, R. I., Blaut, M., & Flint, H. J. (2003) · Applied and Environmental Microbiology

Gut microbiota and healthMicrobial Community Ecology and Physiology

Cited by 350

Altered Gut Microbiome Composition and Tryptic Activity of the 5xFAD Alzheimer’s Mouse Model

Brandscheid, C., Schuck, F., Reinhardt, S., Schäfer, K.-H., Pietrzik, C. U., Grimm, M., Hartmann, T., Schwiertz, A., & Endres, K. (2017) · Journal of Alzheimer s Disease

Gut microbiota and healthAlzheimer's disease research and treatments

Cited by 318

Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson's disease

Schwiertz, A., Spiegel, J., Dillmann, U., Grundmann, D., Bürmann, J., Faßbender, K., Schäfer, K.-H., & Unger, M. M. (2018) · Parkinsonism & Related Disorders

Parkinson's Disease Mechanisms and TreatmentsGastrointestinal motility and disorders

Cited by 318

Weight gain in anorexia nervosa does not ameliorate the faecal microbiota, branched chain fatty acid profiles and gastrointestinal complaints

Mack, I., Cuntz, U., Grämer, C., Niedermaier, S., Pohl, C., Schwiertz, A., Zimmermann, K., Zipfel, S., Enck, P., & Penders, J. (2016) · Scientific Reports

Gut microbiota and healthEating Disorders and Behaviors

Cited by 313

Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice

Ritze, Y., Bárdos, G., Claus, A., Ehrmann, V., Bergheim, I., Schwiertz, A., & Bischoff, S. C. (2014) · PLoS ONE

Probiotics and Fermented FoodsLiver Disease Diagnosis and Treatment

Cited by 292

Effect of Parkinson’s Disease and Related Medications on the Composition of the Fecal Bacterial Microbiota

Weis, S., Schwiertz, A., Unger, M. M., Becker, A., Faßbender, K., Ratering, S., Kohl, M., Schnell, S., Schäfer, K.-H., & Egert, M. (2019) · npj Parkinson s Disease

Gut microbiota and healthParkinson's Disease Mechanisms and Treatments

Cited by 145

Effects of Resistant Starch on Symptoms, Fecal Markers, and Gut Microbiota in Parkinson’s Disease — The RESISTA-PD Trial

Becker, A., Schmartz, G. P., Gröger, L., Grammes, N., Galata, V., Philippeit, H., Weiland, J., Ludwig, N., Meese, E., Tierling, S., et al. (2022) · Genomics, Proteomics & Bioinformatics

Gut microbiota and healthParkinson's Disease Mechanisms and Treatments

Cited by 102

Effects of Resistant Starch on Symptoms, Fecal Markers and Gut Microbiota in Parkinson’s Disease – The RESISTA-PD Trial

Becker, A., Schmartz, G. P., Gröger, L., Grammes, N., Galata, V., Philippeit, H., Weiland, J., Ludwig, N., Meese, E., Tierling, S., et al. (2021) · Genomics Proteomics & Bioinformatics

Gut microbiota and healthParkinson's Disease Mechanisms and Treatments

Cited by 102

The effects of ageing on the colonic bacterial microflora in adults

Enck, P., Zimmermann, K., Rusch, K., Schwiertz, A., Klosterhalfen, S., & Frick, J.-S. (2009) · Zeitschrift für Gastroenterologie

Gut microbiota and healthProbiotics and Fermented Foods

Cited by 68